Established in 2010, LNC Therapeutics has already raised €22.7M.
We are backed by renowned and valuable investors.
Seventure Partners / Health For Life Capital, Europe’s leading microbiome innovation investment fund, is our historic lead investor.
Three family offices have also backed LNC, as well as public investors, including the Nouvelle Aquitaine region. We also received support from BPI France.
To achieve our ambitious strategy to become a leading biotech company in the development of microbiome-based therapies, we are open to welcome new investors in our portfolio.